Huntington National Bank Acquires 504 Shares of Iradimed Corporation (NASDAQ:IRMD)

Huntington National Bank increased its holdings in shares of Iradimed Corporation (NASDAQ:IRMD) by 51.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,487 shares of the medical equipment provider’s stock after acquiring an additional 504 shares during the period. Huntington National Bank’s holdings in Iradimed were worth $75,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of IRMD. 1620 Investment Advisors Inc. bought a new position in shares of Iradimed during the second quarter valued at $25,000. Isthmus Partners LLC raised its holdings in Iradimed by 1.1% in the second quarter. Isthmus Partners LLC now owns 72,664 shares of the medical equipment provider’s stock worth $32,000 after buying an additional 759 shares during the last quarter. Comerica Bank lifted its stake in shares of Iradimed by 2,151.6% in the first quarter. Comerica Bank now owns 1,441 shares of the medical equipment provider’s stock worth $63,000 after buying an additional 1,377 shares in the last quarter. SG Americas Securities LLC purchased a new stake in shares of Iradimed during the third quarter valued at approximately $147,000. Finally, EntryPoint Capital LLC bought a new stake in shares of Iradimed during the first quarter valued at approximately $150,000. Hedge funds and other institutional investors own 92.34% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Roth Mkm lowered their price objective on Iradimed from $65.00 to $60.00 and set a “buy” rating on the stock in a research report on Friday, August 2nd.

Iradimed Stock Performance

NASDAQ IRMD opened at $51.05 on Tuesday. The company has a market capitalization of $646.96 million, a price-to-earnings ratio of 35.66 and a beta of 0.79. The stock has a 50-day moving average of $50.60 and a 200 day moving average of $46.52. Iradimed Corporation has a one year low of $40.05 and a one year high of $57.95.

Iradimed Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, November 25th. Stockholders of record on Friday, November 15th will be paid a $0.15 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 1.18%. Iradimed’s dividend payout ratio is presently 41.10%.

Iradimed Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.